New Vice President Clinical Development at IBT
August 16, 2016


IBT is welcoming Agneta Heierson as Vice President Clinical Development. She has over 25 years of experience working in the pharmaceutical industry. Most recently she has been the Global Vice President, R&D Supply Chain at AstraZeneca. Her extensive experience includes leading both global cross-functional drug development projects across all phases of development in different therapeutic areas, as well as leading clinical and pharmaceutical development organisations.


See Who we are here